Medicover AB (publ) (LON:0RPS)
273.50
+0.75 (0.27%)
At close: Aug 20, 2025
Medicover AB Revenue
Medicover AB had revenue of 596.70M EUR in the quarter ending June 30, 2025, with 17.14% growth. This brings the company's revenue in the last twelve months to 2.26B, up 18.20% year-over-year. In the year 2024, Medicover AB had annual revenue of 2.09B with 19.78% growth.
Revenue (ttm)
2.26B EUR
Revenue Growth
+18.20%
P/S Ratio
1.65
Revenue / Employee
47.79K EUR
Employees
47,256
Market Cap
3.20B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.09B | 345.40M | 19.78% |
Dec 31, 2023 | 1.75B | 236.20M | 15.64% |
Dec 31, 2022 | 1.51B | 132.80M | 9.64% |
Dec 31, 2021 | 1.38B | 379.60M | 38.04% |
Dec 31, 2020 | 997.80M | 153.40M | 18.17% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Oxford Nanopore Technologies | 183.19M |